Analyst Andrew Fein of H.C. Wainwright maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), boosting the price target to ...

Needham analyst Ryan MacDonald has reiterated their bullish stance on COUR stock, giving a Buy rating yesterday.Invest with Confidence: Follow ...

However, high correlation to crude can be a double-edged sword, as many energy investors experienced when crude prices ...

Stock ratings can range from simple “buy” and “sell” ratings to “equal weight” and “outperform” ratings. Here’s a quick overview of how analysts rate stocks. A “buy” rating ...

The near term technicals are highly bullish as the chart, moving averages, and indicators show that the outlook is strong.

Obin's raised price objective is based on an 18x EV/EBITDA multiple applied to the firm's 2026 estimates, which is an ...

Here are three smaller-cap companies with lower-priced stocks that could offer patient investors enormous returns for the ...

We recently published a list of 10 Unstoppable Stocks to Buy in 2025. In this article, we are going to take a look at where ...